- Home
- RDCM vs DERM Comparison
RDCM vs DERM Comparison
Compare RDCM & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- DERM
- Stock Information
- Founded
- RDCM 1985
- DERM 2014
- Country
- RDCM Israel
- DERM United States
- Employees
- RDCM N/A
- DERM N/A
- Industry
- RDCM Computer peripheral equipment
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- RDCM Technology
- DERM Health Care
- Exchange
- RDCM Nasdaq
- DERM Nasdaq
- Market Cap
- RDCM 203.7M
- DERM 165.6M
- IPO Year
- RDCM 1997
- DERM 2021
- Fundamental
- Price
- RDCM $14.64
- DERM $7.17
- Analyst Decision
- RDCM Strong Buy
- DERM Strong Buy
- Analyst Count
- RDCM 1
- DERM 3
- Target Price
- RDCM $18.00
- DERM $12.67
- AVG Volume (30 Days)
- RDCM 58.5K
- DERM 134.4K
- Earning Date
- RDCM 11-12-2025
- DERM 11-11-2025
- Dividend Yield
- RDCM N/A
- DERM N/A
- EPS Growth
- RDCM 79.61
- DERM N/A
- EPS
- RDCM 0.56
- DERM N/A
- Revenue
- RDCM $66,334,000.00
- DERM $56,397,000.00
- Revenue This Year
- RDCM $18.07
- DERM $28.10
- Revenue Next Year
- RDCM $11.52
- DERM $53.84
- P/E Ratio
- RDCM $25.35
- DERM N/A
- Revenue Growth
- RDCM 18.18
- DERM N/A
- 52 Week Low
- RDCM $9.42
- DERM $3.54
- 52 Week High
- RDCM $15.98
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- RDCM 62.18
- DERM 48.65
- Support Level
- RDCM $13.68
- DERM $7.00
- Resistance Level
- RDCM $14.68
- DERM $7.12
- Average True Range (ATR)
- RDCM 0.55
- DERM 0.27
- MACD
- RDCM 0.12
- DERM -0.00
- Stochastic Oscillator
- RDCM 96.91
- DERM 45.86
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.